Cargando…
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd-ba...
Autores principales: | Rees, Julian A., Deblonde, Gauthier J.-P., An, Dahlia D., Ansoborlo, Camille, Gauny, Stacey S., Abergel, Rebecca J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849765/ https://www.ncbi.nlm.nih.gov/pubmed/29535330 http://dx.doi.org/10.1038/s41598-018-22511-6 |
Ejemplares similares
-
Efficient discrimination of transplutonium actinides by in vivo models
por: Pallares, Roger M., et al.
Publicado: (2021) -
Combinatorial design of multimeric chelating peptoids for selective metal coordination
por: Ricano, Abel, et al.
Publicado: (2019) -
In situ beam reduction of Pu(IV) and Bk(IV) as a route to trivalent transuranic coordination complexes with hydroxypyridinone chelators
por: Carter, Korey P., et al.
Publicado: (2022) -
The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017) -
Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)